| Neri B, Molinara E, Pantaleo P, et al. Weekly administration of docetaxel and epirubicin as first-line treatment for hormone-refractory prostate carcinoma. [Journal Article, Research Support, Non-U.S. Gov't] Oncol Res 2009; 17(11-12):565-70. Abstract | Full Citation | | Gadaleta C, Catino A, Ranieri G, et al. Single-step Therapy -- Feasibility and Safety of Simultaneous Transarterial Chemoembolization and Radiofrequency Ablation for Hepatic Malignancies. [Journal Article] In Vivo 2009 Sep-Oct; 23(5):813-20. Abstract | Full Citation | Find Related Articles | | Birare N, Lwaleed BA, Cooper AJ Multidrug resistance in a urothelial cancer cell line after 1-hour mitomycin C exposure. [Journal Article] J Urol 2009 Nov; 182(5):2472-6. Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jagt CT, Zuckermann M, Ten Kate F, et al. Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico-pathological analysis. [JOURNAL ARTICLE] Pediatr Blood Cancer 2009 Aug 11. Abstract | Full Citation | | Li Y, Zou D, Zhao Y, et al. Clinical Characteristics and Treatment Outcome of Adult Acute Lymphoblastic Leukemia with t(4;11)(q21;q23) Using a Modified Hyper-CVAD Regimen. [JOURNAL ARTICLE] Acta Haematol 2009 Aug 6; 122(1):23-26. Full Citation | | Turan Y, Kocaaga Z, Karakoyun-Celik O, et al. Osteoporosis in women with breast cancer and its effect on quality of life: a pilot study. [Journal Article] J BUON 2009 Apr-Jun; 14(2):239-43. Abstract | Full Citation | Find Related Articles | | Schmitt M, Sweep FC Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer. [JOURNAL ARTICLE] Eur J Cancer 2009 Jul 31. Full Citation | Find Related Articles | | Zhao L, Pan Y, Gang Y, et al. Identification of GAS1 as an epirubicin resistance related gene in human gastric cancer cells with a partially randomized siRNA library. [JOURNAL ARTICLE] J Biol Chem 2009 Jul 28. Abstract | Full Citation | Find Related Articles | | Kim SJ, Taguchi T, Shimazu K, et al. Good Response to Paclitaxel Predicts High Rates of Pathologic Complete Response for Breast Cancer Patients Treated Preoperatively with Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide. [JOURNAL ARTICLE] Oncology 2009 Jul 23; 77(2):134-139. Abstract | Full Citation | | Warm M, Kates R, Thomas A, et al. Side-effects of Pre-operative Epirubicin-Paclitaxel Therapy in Primary Breast Cancer Associated with Tumor Biology. [Journal Article] Anticancer Res 2009 Jul; 29(7):2675-80. Abstract | Full Citation |  |
|
| | Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo Advertise on this site.
|